Quest Diagnostics study featured in Diabetes Care
Do you test for hemoglobin A1c (HbA1c) in your employee wellness screening program? If you don’t, your employees may be missing out on valuable knowledge about their risk for type 2 diabetes.
In the current issue of Diabetes Care, an American Diabetes Association® journal, Quest Diagnostics shows that testing for HbA1c as well as fasting glucose is an essential strategy for population health programs. Testing both measures helps organizations identify individuals at risk for type 2 diabetes and intervene before those individuals become high-cost claimants.
Insights from Quest Diagnostics
Sign up to receive the latest news and insights about health and well-being.
Thanks for signing up!
You’re all set to begin receiving white papers from Quest Diagnostics.